CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Biogen's Q2 Earnings Beat, New Drugs Drive Sales, 2026 Guidance Raised

EarningsPositive
AI Analysis

Summary

Biogen reported Q2 earnings that beat expectations, with new drugs contributing to sales growth and the company raising its 2026 guidance.

Financial Highlights

Guidance

2026 guidance raised

Importance:6/10
Sentiment:
0.70
earningsQ2guidance_raisednew_drugs
Related Companies

Read the original article

Published by yahoo_finance on July 29, 2026 3:09 PM

Read Original